James Mulry has been named director of marketing, hematology for Clinical Data (Newton, Massachusetts). Prior to joining Clinical Data, Mulry was vice president of sales and marketing at ABX Diagnostics. Clinical Data, through its subsidiaries, provides a complete range of products and consulting services to the physician's office laboratory market and offers blood chemistry instrumentation and diagnostic assays to clinics and small hospitals throughout the world.

Richard Lanman, MD, was appointed executive vice president and chief medical officer of diaDexus (South San Francisco, California). Prior to joining diaDexus, Lanman served as executive vice president, corporate business development, and chief medical officer at Atherotech. Lanman also was founder, chairman and CEO of Adesso Healthcare Technology Services. diaDexus, a privately held biotechnology company, is focused on the development of new diagnostic and therapeutic products with high clinical value.

Scott Kahn, PhD, has been named vice president and chief information officer for Illumina (San Diego). Kahn previously was chief scientific officer at Accelerys. Illumina is developing next-generation tools enabling large-scale analysis of genetic variation and function.

James Thrall, MD, was elected chairman of the board of Mobile Aspects (Pittsburgh), a provider of radio frequency identification tracking solutions for the healthcare industry. Thrall, a member of Mobile Aspects' board of directors since 2002, has been radiologist-in-chief at Massachusetts General Hospital since 1988. In addition, he holds the Juan M. Taveras Professorship of Radiology at Harvard Medical School and serves on the executive committee of the Harvard Department of Radiology.

John Giddings has been appointed CEO of Oakfield Instruments (Morrisville, North Carolina), an esophageal and urology diagnostic equipment provider. Giddings was formerly the sales and marketing director of Oakfield Instruments and has held several senior positions within the organization. He has extensive experience in the healthcare industry and previously worked for Baxter Healthcare and Smith & Nephew in the UK.

Pamela Bunes has been named CEO and president of Recom Managed Systems (Los Angeles). Bunes was named to Recom's board of directors last month. She also was acting as a consultant to the company. Dr. Lowell Harmison, former principal deputy of the U.S. Department of Health and Human Services, will continue in his roles as a consultant and a director of the company and will assist Bunes as Recom's co-CEO throughout the period of transition. Bunes most recently was employed by Biosense Webster, a Johnson & Johnson subsidiary. Recom Managed Systems is an emerging life sciences company focused on the monitoring and detection of disease through continuous biomedical signal monitoring.

John Kuo has been promoted by Varian Medical Systems (Palo Alto, California) to serve as corporate vice president and general counsel, effective July 2. Kuo, currently Varian's corporate secretary and associate general counsel, is replacing Joseph Phair, corporate vice president and general counsel, who will retire after 26 years with the company. Varian Medical Systems is a manufacturer of integrated cancer therapy systems and a supplier of X-ray tubes and flat-panel digital subsystems.